Beyaz Drug Interactions
Currently displaying 84 drugs known to have a major interaction with Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium).
- 84 major drug interactions
- 440 moderate drug interactions
- 42 minor drug interactions
Major interactions with Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium)
Note: Showing generic names only.
- relugolix
- repotrectinib
- rifabutin
- rifampin
- rifapentine
- ritlecitinib
- ritonavir
- ruxolitinib
- ruxolitinib topical
- telaprevir
- telithromycin
- testolactone
- thalidomide
- tizanidine
- tofacitinib
- topiramate
- tovorafenib
- tranexamic acid
- troleandomycin
- tucatinib
Beyaz alcohol/food interactions
There are 5 alcohol/food interactions with Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium).
Beyaz disease interactions
There are 20 disease interactions with Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium) which include:
- smoking
- hyperkalemia
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- bipolar disorder
More about Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium)
- Beyaz consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (169)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: contraceptives
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.